PocDoc partners with NHS Targeted Lung Health Programme in North East, leveraging new biomarker Coronary Artery Calcium, to identify patients at increased risk of cardiovascular disease
But these scans also identify the early stages of another common killer – coronary heart disease.
- But these scans also identify the early stages of another common killer – coronary heart disease.
- Discovering these higher risk patients who have evidence of early disease, but are not already taking a statin, is an optimal way to maximise the health outcomes of the TLHC program.
- The PocDoc pathway collects all the information needed for a cardiovascular risk assessment, including blood pressure and BMI.
- We are proud to be partnering with PocDoc to demonstrate the North East's commitment to using innovation to save lives."